Product Commercialization

Expand into global markets faster with culturally relevant and compliant messaging. Choose centralized content solutions that ensure native-level localized translation, meet varied regulatory requirements on a region-by-region basis, and increase your speed to global launch.

Get in Touch
Person using iPad to analyze metrics

Comprehensive Support for Product Launches and Commercialization Plans

By partnering with TransPerfect, your team will increase preparation efficiency and shorten time to launch. Discover our complete suite of global product launch solutions.

    Digital Marketing

    Obtain strategic guidance on your omnichannel digital marketing efforts and website localization with our TPT Digital solution. Drive visibility to global marketing campaigns and create targeted messaging for your commercialization plan based on the customer journey.

    Learn More

    Translation Services

    We offer powerful technology to enable faster, more accurate translations of your product launch collateral such as app, website, brochure, and e-learning materials. TransPerfect’s GlobalLink TMS automates manual steps, drives consistency through central TMs and linguistic assets, incorporates MT workflows, and offers real-time reporting for greater visibility and control.

    Learn More

    Social Listening

    Meet with experts to review keyword requirements, search terms, and translations. TransPerfect centralizes the review of literature and streamlines the monitoring of all major social channels to understand the global sentiment around your brand.

    Learn More

    Multicultural Marketing Consulting

    Work with TransPerfect’s cultural consultants to identify your target market, how to best adapt existing marketing content, and create original content and materials that will produce the desired results.

    Learn More

    Trusted by Life Sciences Organizations Big and Small

    With TransPerfect’s support, Novartis, Pfizer, and Merck have created an average of more than $5M in savings. Partnering with TransPerfect has significantly reduced their product localization costs and made it possible for their products to launch up to 50% faster than the competition.

    Novartis
    Pfizer logo
    Merck
    Get a Free Consult ›

    Better Product Commercialization Launches by the Numbers

    30 %

    Faster Product Launch Times

    100 %

    Regulatory Compliance

    $ 5 M

    Average Saved by Novartis, Pfizer, and Merck in Product Localization

    Ready to accelerate your product launch and commercialization?

    Get in Touch ›

    News and Thought Leadership

    View industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexities and bring breakthroughs from lab to launch.

    IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

    Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across multiple systems, vendors and stakeholders, teams often face avoidable rework, conflicting label text versions, delayed translations, unclear approval pathways and change control gaps that can ...

    IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays
    Event

    C3 Summit 2026 - London

    Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...
    Blog

    Considerations for eCOA in Global Clinical Trials

    Regulatory Considerations for eCOA Submissions in Global Clinical Trials: What You Need to KnowWhen managing eCOA in clinical trials across multiple countries, translation, linguistic validation, and electronic implementation of Clinical Outcome Assessments (COAs) are...
    Webinar

    Xtalks | EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities

    The EU clinical trial landscape has changed significantly since Regulation (EU) No 536/2014 became applicable on January 31, 2022, and sponsors now need a clear view of how the framework is operating in practice and where it may evolve next. This webinar explores the current ...
    Checklist

    Veeva RIM TMS Integration Checklist

    If your regulatory team is still downloading documents from Veeva Vault, managing translation requests by email, or tracking submissions in spreadsheets, there's a better way. Reduce complexity, close compliance gaps, and shorten your submission cycle times with this ...
    White Paper

    The Current State of AI in Translation for Clinical Content

    AI is reshaping how clinical trial content gets translated and localized, but in a regulated environment, speed can't come at the cost of accuracy or traceability. This white paper breaks down where AI delivers real value, where human oversight remains essential, and how to ...
    Guide

    The Veeva Vault RIM Translation Integration

    Managing multilingual regulatory submissions shouldn't mean chasing files across email threads and re-entering metadata by hand. This playbook breaks down how direct translation integration with Veeva Vault RIM eliminates manual bottlenecks, preserves compliance, and cuts ...